CRISPR Based Technologies and Bio-products
Genome piece of writing and the utilization of CRISPR based technologies are expected to revolutionize the assembly of succeeding generation of bio product. DCB12 will consider the foremost recent developments among the use of CRISPR/Cas9 and different CRISPR based technologies in relevance the event and production of biopharmaceuticals, biochemical, agricultural crops and travel applications. The worldwide marketplace for genetic modification therapies should grow from $2.3 billion in 2018 to achieve $17.4 billion by 2023, growing at a compound annual rate of growth (CAGR) of 49.9% during the forecast period of 2018-2023.
Related Conference of CRISPR Based Technologies and Bio-products
March 09-10, 2026
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
CRISPR Based Technologies and Bio-products Conference Speakers
Recommended Sessions
- Algal Biotechnology
- Animal Biotechnology
- Bio Economy
- Biomass and Bioenergy
- Biotechnology
- Biotechnology and Bioprocess Engineering
- Biotechnology Applications
- Biotechnology Capital & Grants
- Biotechnology Companies & Market Analysis
- Biotechnology Enterprise and Entrepreneurship
- Biotechnology Products
- Cell/Molecular Biotechnology
- CRISPR Based Technologies and Bio-products
- Environmental Biotechnology
- Europe Biotech Market
- Food Biotechnology
- Genetic Engineering
- Industrial Biotechnology
- Marine Biotechnology
- Medical Biotechnology
- Nano Biotechnology
- Pharmaceutical Biotechnology
- Plant and Agriculture Biotechnology
- Stem Cell Biotechnology
- Systems and Synthetic Biotechnology
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)